AlphaStreet Newsdesk powered by AlphaStreet Intelligence
SCL|EPS $0.45 vs $0.44 est (+2.3%)|Rev $604.5M|Net Loss $41.4MStepan Company reported first-quarter adjusted earnings of $0.45 per share, edging past the Wall Street consensus estimate of $0.44 by 2.3%. The specialty and intermediate chemicals manufacturer posted revenue of $604.5M, up 2.0% from the $593.3M recorded in Q1 2025. Adjusted net income reached $10.3M for the quarter.
The modest top-line growth came despite flat organic sales volume for the period. Stepan’s diverse chemical portfolio serves manufacturers across multiple end markets in the United States, France, Poland and other global markets, providing stability even as volume remained unchanged year-over-year.
The company’s Surfactants segment drove performance with $453.7M in revenue, up 5.0% year-over-year, leading the quarterly results. Surfactants, which are used in consumer and industrial cleaning products, personal care items and other applications, remain the core of Stepan’s business model.
Wall Street maintains a constructive view on the stock, with analyst consensus standing at 3 buy ratings, 1 hold and 0 sell recommendations. The earnings beat, though narrow, demonstrates the company’s ability to deliver on expectations in a challenging environment for specialty chemical producers.
A detailed analysis of Stepan Company’s quarter follows shortly on AlphaStreet.
This content is for informational purposes only and should not be considered investment advice. AlphaStreet Intelligence analyzes financial data using AI to deliver fast and accurate market information. Human editors verify content.